No Data
No Data
No Data
No Data
No Data
Gelonghui announcement selection | Puri Ophthalmology: Net profit in 2023 increased 1202.56% year-on-year, and plans to pay 10 to 4 yuan; Jie'an Hi-Tech: The company's military virtual simulation training products account for a small share of the company'
[Contract won] Zhonglai Co., Ltd. (300393.SZ): The consortium won the bid for 2,756 billion yuan household photovoltaic-related project, Zhonglai Shares (300393.SZ) announced that the company's holding subsidiary Suzhou Zhonglai Minsheng Energy Co., Ltd. (“Zhonglai Minsheng”) and its wholly-owned subsidiary Zhonglai Zhilian Energy Engineering Co., Ltd. (“Zhonglai Zhilian”) consortium previously won the bid for the “Zhejiang Zhejiang Energy Service Co., Ltd. Second Batch Household Photovoltaic Project Engineering General Contracting (EPC) Framework Agreement Procurement Project”. The “Winning Bid “Notice”, the winning bid price was 27
Gelonghui FinanceApr 23 11:49 ET
The Recent CN¥751m Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)
Key Insights Insiders appear to have a vested interest in Chengdu Bright Eye Hospital's growth, as seen by their sizeable ownership A total of 3 investors have a majority stake in the company with 5
Simply Wall StApr 13 21:10 ET
The Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Don't Inspire Confidence
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and second
Simply Wall StMar 9 19:28 ET
Puri Ophthalmology (301239.SZ): A total cost of 59.77 million yuan to buy back 0.5% of shares
Gelonghui, March 1 | Puri Ophthalmology (301239.SZ) announced that as of March 1, 2024, the total number of shares repurchased by the company through centralized bidding transactions through a special securities repurchase account was 755,267 shares, accounting for 0.50% of the company's total share capital. The highest transaction price was 102.00 yuan/share, the minimum transaction price was 54.94 yuan/share, and the transaction amount was 59,770,175.60 yuan (excluding transaction fees). At this point, the company's actual repurchase amount has reached the lower limit of the total repurchase capital in the repurchase plan, and has not exceeded the maximum limit of the total repurchase capital. The actual repurchase period is 2
Gelonghui FinanceMar 1 06:52 ET
Does Chengdu Bright Eye Hospital (SZSE:301239) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Simply Wall StFeb 12 01:17 ET
Declining Stock and Solid Fundamentals: Is The Market Wrong About Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)?
Chengdu Bright Eye Hospital (SZSE:301239) has had a rough three months with its share price down 24%. But if you pay close attention, you might gather that its strong financials could mean that the
Simply Wall StJan 16 18:43 ET
No Data
No Data